Fusion Genomics Corporation
Fusion Genomics Corporation develops reagents, automation, and analytics for targeted metagenomic workflows in hospital labs.
Profile
They develop tools and analytics for targeted metagenomic workflows in hospital labs.
Fusion Genomics Corporation develops reagents, automation, and analytics for targeted metagenomic workflows in hospital labs. Founded to address the critical-care gap in microbiology, the company focuses on enabling accredited laboratories to deploy efficient, broad-spectrum metagenomic workflows. Their flagship product, ONETest™, uses QuantumProbes™ to enrich microbial genomic signal while preserving a representative view of the microbial community.
FusionCloud™, their AI-driven analytics platform, supports organism prioritization, antimicrobial resistance (AMR) marker context, and interpretation evidence. The company’s technology is designed to reduce the complexity and cost of metagenomics, making it more accessible for routine hospital use. Fusion Genomics’ products are currently for research use only (RUO) and require independent validation for clinical applications.
The company operates in a competitive market where untargeted metagenomics and traditional PCR-based methods remain prevalent. Fusion Genomics’ approach aims to bridge the gap between broad-spectrum detection and actionable insights, particularly in complex infections where traditional methods fall short.
Who buys this
- Hospital laboratories
- Accredited clinical labs
- Research institutions
- Biotechnology companies
Strengths and what to watch
Strengths
- ONETest™ enriches microbial signal while preserving community context.
- FusionCloud™ AI provides actionable intelligence for microbial prioritization.
- Integrated platform reduces workflow complexity for metagenomics.
Watch for
- Products are currently RUO, limiting immediate clinical adoption.
- Competition from established PCR and untargeted metagenomics providers.
- Dependence on lab validation for clinical deployment.
Key Information
- Founded
- 2013
- Headquarters
- Burnaby, British Columbia, Canada
Frequently Asked Questions
What does Fusion Genomics Corporation do?
Fusion Genomics develops reagents, automation, and analytics for targeted metagenomic workflows in hospital labs. Their ONETest™ and FusionCloud™ platform help labs detect microbial communities efficiently, with AI-driven insights for infection analysis. Currently for research use, their tools aim to simplify complex metagenomics for clinical settings.
How does ONETest™ work for microbial detection?
ONETest™ uses QuantumProbes™ technology to enrich microbial genomic signals while maintaining a representative view of the microbial community. This targeted approach improves detection sensitivity compared to traditional methods, particularly for complex infections where broad-spectrum analysis is needed but standard PCR may miss key pathogens.
What is FusionCloud™ used for in metagenomics?
FusionCloud™ is an AI-driven analytics platform that helps labs interpret metagenomic data. It prioritizes detected organisms, identifies antimicrobial resistance markers, and provides evidence-based interpretation. This supports faster, more actionable insights from complex infection samples compared to manual analysis methods.
Can hospitals currently use Fusion Genomics' products for patient care?
No, Fusion Genomics' products are currently for research use only (RUO). Labs must independently validate the technology for clinical applications. This status reflects the regulatory pathway for novel metagenomic tools entering clinical microbiology practice.
How does targeted metagenomics differ from traditional PCR testing?
Targeted metagenomics captures a broader range of microbial DNA in one test compared to single-pathogen PCR assays. Fusion Genomics' approach enriches microbial signals while preserving community context, offering advantages for complex infections where the causative agent isn't known beforehand.
What types of labs use Fusion Genomics' technology?
Hospital laboratories, accredited clinical labs, research institutions, and biotech companies use Fusion Genomics' tools. Their solutions are designed for settings needing efficient, broad-spectrum microbial detection, particularly where traditional methods may miss polymicrobial or novel infections.
Sources
- www.fusiongenomics.com — Company overview and product details.
- www.sec.gov — Financial and operational context.
- www.sec.gov — Regulatory and financial filings.
- techcrunch.com — Industry context and competitive landscape.